- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of Mcl-1 by SRSF1 and SRSF5 in Cancer Cells
Authors
Keywords
Small interfering RNAs, Transfection, Apoptosis, Alternative splicing, RNA-binding proteins, Polymerase chain reaction, Breast cancer, Reverse transcriptase-polymerase chain reaction
Journal
PLoS One
Volume 7, Issue 12, Pages e51497
Publisher
Public Library of Science (PLoS)
Online
2012-12-18
DOI
10.1371/journal.pone.0051497
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance
- (2012) Rong Jia et al. International Journal of Biological Sciences
- The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation
- (2012) Olga Anczuków et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo
- (2010) Clint Mitchell et al. CANCER BIOLOGY & THERAPY
- Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E
- (2010) Andrew C. Hsieh et al. CANCER CELL
- Identification of ASF/SF2 as a Critical, Allele-Specific Effector of the Cyclin D1b Oncogene
- (2010) N. A. Olshavsky et al. CANCER RESEARCH
- An Alternative Splicing Network Links Cell-Cycle Control to Apoptosis
- (2010) Michael J. Moore et al. CELL
- Mcl-1; the molecular regulation of protein function
- (2010) Luke W. Thomas et al. FEBS LETTERS
- A Splicing-Independent Function of SF2/ASF in MicroRNA Processing
- (2010) Han Wu et al. MOLECULAR CELL
- The MCL-1 BH3 helix is an exclusive MCL-1 inhibitor and apoptosis sensitizer
- (2010) Michelle L Stewart et al. Nature Chemical Biology
- A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy
- (2010) W J Placzek et al. Cell Death & Disease
- Mitochondrial cell death effectors
- (2009) Dirk Brenner et al. CURRENT OPINION IN CELL BIOLOGY
- Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways
- (2009) Vânia Gonçalves et al. HUMAN MOLECULAR GENETICS
- Modification of Alternative Splicing of Mcl-1 Pre-mRNA Using Antisense Morpholino Oligonucleotides Induces Apoptosis in Basal Cell Carcinoma Cells
- (2009) Jeng-Jer Shieh et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation
- (2009) L A Pradelli et al. ONCOGENE
- Identification of Alternative Splicing Markers for Breast Cancer
- (2008) J. P. Venables et al. CANCER RESEARCH
- Mcl-1 is a potential therapeutic target in multiple types of cancer
- (2008) C. Akgul CELLULAR AND MOLECULAR LIFE SCIENCES
- The emerging role of splicing factors in cancer
- (2008) Ana Rita Grosso et al. EMBO REPORTS
- Down-Regulation of Mcl-1 by Small Interfering RNA Sensitizes Resistant Melanoma Cells to Fas-Mediated Apoptosis
- (2008) N. Chetoui et al. MOLECULAR CANCER RESEARCH
- SF2/ASF TORCs Up Translation
- (2008) Martin Bushell et al. MOLECULAR CELL
- The Splicing Factor SF2/ASF Regulates Translation Initiation by Enhancing Phosphorylation of 4E-BP1
- (2008) Gracjan Michlewski et al. MOLECULAR CELL
- The splicing-factor oncoprotein SF2/ASF activates mTORC1
- (2008) R. Karni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- mTORC1 promotes survival through translational control of Mcl-1
- (2008) J. R. Mills et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The BCL-2 protein family: opposing activities that mediate cell death
- (2007) Richard J. Youle et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More